Colorectal, Cancer Clinical Trials in Florence, Firenze
2 recruitingFlorence, Firenze, Italy
Showing 1–2 of 2 trials
Recruiting
Phase 2
A Study to Assess Adverse Events and Change in Disease Activity in Adult Participants Receiving Intravenously Infused Telisotuzumab Adizutecan Alone or With Standard of Care in Participants With Post Adjuvant Circulating Tumor DNA Positive Colorectal Cancer and No Radiographic Evidence of Disease
Colorectal, Cancer
AbbVie140 enrolled41 locationsNCT07023289
Recruiting
Phase 2
Upfront Trastuzumab-Deruxtecan Plus Capecitabine and Bevacizumab for Patients With HER-2 Positive Metastatic Colorectal Cancer.
Colorectal, CancerRectal AdenocarcinomaColorectal Adenocarcinoma+4 more
Gruppo Oncologico del Nord-Ovest42 enrolled28 locationsNCT07407465